Healthcare in Saudi Arabia / NEOM
Building a production pharmaceutical system in Saudi Arabia / NEOM from zero requires FDA 21 CFR Part 11 validation architecture, UAE PDPL and DIFC compliance, and GxP documentation embedded from the first system design. Validated systems are designed for validation — not validated after they are built.
Pharmaceutical technology lives under FDA 21 CFR Part 11. Data integrity isn't optional — it's existential. Clinical trial data, manufacturing execution, regulatory submissions — every system requires validated, compliant infrastructure.
How We Deliver in Saudi Arabia / NEOM
UAE & Gulf and Healthcare Frameworks
Healthcare organizations in Saudi Arabia / NEOM operate under both UAE & Gulf regional frameworks and sector-specific compliance requirements. We embed all applicable frameworks architecturally — not as a parallel compliance workstream running alongside engineering.